1. Home
  2. SLGL

as 09-18-2025 4:00pm EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

Founded: 1997 Country:
Israel
Israel
Employees: N/A City: N/A
Market Cap: 69.1M IPO Year: 2018
Target Price: N/A AVG Volume (30 days): 32.9K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.22 EPS Growth: N/A
52 Week Low/High: $4.01 - $30.00 Next Earning Date: 11-14-2025
Revenue: $23,931,000 Revenue Growth: 264.86%
Revenue Growth (this year): -31.93% Revenue Growth (next year): 31.17%

SLGL Daily Stock ML Predictions

Share on Social Networks: